Sg Americas Securities, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023
BUY
$0.89 - $2.52 $23,986 - $67,916
26,951 New
26,951 $24,000
Q4 2021

Feb 07, 2022
SELL
$5.12 - $8.19 $115,962 - $185,495
-22,649 Closed
0 $0
Q3 2021

Nov 01, 2021
BUY
$6.68 - $9.1 $151,295 - $206,105
22,649 New
22,649 $151,000
Q3 2020

Nov 09, 2020
SELL
$7.96 - $12.42 $105,645 - $164,838
-13,272 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$5.4 - $13.37 $71,668 - $177,446
13,272 New
13,272 $127,000

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $76.1M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email